| Literature DB >> 25837984 |
Tzu-Wen Liang1, San-Lang Wang2.
Abstract
This review provides a comprehensive summary of the most recent developments of various aspects (i.e., production, purification, structure, and bioactivity) of the exopolysaccharides (EPSs) from Paenibacillus spp. For the production, in particular, squid pen waste was first utilized successfully to produce a high yield of inexpensive EPSs from Paenibacillus sp. TKU023 and P. macerans TKU029. In addition, this technology for EPS production is prevailing because it is more environmentally friendly. The Paenibacillus spp. EPSs reported from various references constitute a structurally diverse class of biological macromolecules with different applications in the broad fields of pharmacy, cosmetics and bioremediation. The EPS produced by P. macerans TKU029 can increase in vivo skin hydration and may be a new source of natural moisturizers with potential value in cosmetics. However, the relationships between the structures and activities of these EPSs in many studies are not well established. The contents and data in this review will serve as useful references for further investigation, production, structure and application of Paenibacillus spp. EPSs in various fields.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25837984 PMCID: PMC4413190 DOI: 10.3390/md13041847
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
EPS production by fermentation of Paenibacillus spp.
| Bacteria Source | Fermentation Conditions | EPS Yield (g/L) | References | ||||
|---|---|---|---|---|---|---|---|
| Medium Composition | Temperature (°C) | pH | Culture Vessel | Period (Days) | |||
| 1.5% SPP, 0.1% K2HPO4, and 0.05% MgSO4·7H2O | 37 | 7.23 | 50 mL in a 250 mL flask at 150 rpm | 5 | 4.55 | [ | |
| 10% SPP, 0.1% K2HPO4, and 0.05% MgSO4·7H2O | 37 | 7.23 | 50 mL in a 250 mL flask at 150 rpm | 5 | 41.25 | ||
| 2% SPP, 0.1% K2HPO4, and 0.05% MgSO4·7H2O | 30 | 7.21 | 100 mL in a 250 mL flask at 150 rpm | 4 | 3.46 | [ | |
| 10% SPP, 0.1% K2HPO4, and 0.05% MgSO4·7H2O | 30 | 7.21 | 100 mL in a 250 mL flask at 150 rpm | 4 | 35.75 | ||
| Galactose 48.5 g/L, Fe3+ 242 µM and Ca2+ 441 µM | 30 | 6.5 | 250 mL in a 1 L flask | 4 | 3.44 | [ | |
| 5 g/L yeast extract | 30–40 | 1 L in 2 L Jar fermenter: agitation speed, 500 rpm | [ | ||||
| Sucrose 188.2 g/L, yeast extract 25.8 g/L, K2HPO4 5 g/L, CaCl2 0.34 g/L | 24 | 8 | 200 mL in a 1 L flask | 2.5 | 35.26 | [ | |
| 80% olive mill wastewaters (OMW) | 30 | 7 | 2 L bioreactor at 150 rpm | 3 | 4.2 | [ | |
| Sucrose 51.35 g/L, peptone 6.78 g/L and yeast extract 0.47 g/L | 30 | 7.2 | 100 mL in a 250 mL flask at 220 rpm | 4 | 25.63 | [ | |
| Glucose 100 g/L, yeast extract 3 g/L | 50 | 7 | 400 mL in a 1 L flask at 150 rpm | 4 | 6.89 | [ | |
|
| Sucrose 20 g/L, yeast extract 0.2 g/L, K2HPO4 0.25 g/L, MgSO4 ·7H2O 0.1 g/L, NaCl 0.05 g/L, agar 15 g/L | 30 | Petri dishes of 90 mm of diameter | 5 | [ | ||
| MSM broth containing 10% sucrose | 30 | 1 L medium at 180 rpm | 3 | 10 | [ | ||
Figure 1Schematic diagram for the isolation of EPS from Paenibacillus spp.
Chemical structures of EPSs from Paenibacillus spp.
| Microorganisms | Chemical Composition of EPSs | References |
|---|---|---|
| glucose and maltose | [ | |
| Glucose, galactose, mannose, fucose and glucuronic acid | [ | |
| Glucose, mannose, galactose, glucuronic acid and pyruvate | [ | |
| β-(2-6) linked fructan | [ | |
| Glucose:glucuronic acid:xylose:mannose = 1:0.53:1.15:0.46 | [ | |
| linear glucan interconnected by β-(1→3) glucosidic linkages | [ | |
| glucan having β-(1,3) and β-(1,6) linkages | [ | |
| Mannose, fructose and glucose | [ | |
| Mannose, glucose, fructose and glucuronic acid | [ |
Potential applications of EPSs from Paenibacillus spp.
| Microorganisms | EPSs | Applications | References |
|---|---|---|---|
| Antioxidant | [ | ||
| Improvement of human skin hydration | [ | ||
| Levan and its derivatives | Antioxidant | [ | |
| Reduction in the toxicity of olive mill wastewaters | [ | ||
| Bioflocculant | [ | ||
| Curdlan | Drug-delivery carriers for the sustained release of drugs and a support matrix for immobilization of enzymes | [ | |
|
| Removal of cadmium | [ | |
| Antioxidant | [ | ||
| Glucan | Animal feed additive for the purpose of enhancing immunity | [ |